ChiCTR-TRC-11001657 版本V1.2 版本创建时间2015/07/22 13:41:37 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR-TRC-11001657 

最近更新日期:

Date of Last Refreshed on:

2015-07-22 13:18:41 

注册时间:

Date of Registration:

2011-11-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

Music therapy on pain and stress reduction during transvaginal ultrasound-guided oocyte retrieval: a randomized controlled trial

Public title:

Music therapy on pain and stress reduction during transvaginal ultrasound-guided oocyte retrieval: a randomized controlled trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

Music therapy on pain and stress reduction during transvaginal ultrasound-guided oocyte retrieval: a randomized controlled trial

Scientific title:

Music therapy on pain and stress reduction during transvaginal ultrasound-guided oocyte retrieval: a randomized controlled trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

CUHK_CCT00300

申请注册联系人:

Carol Chan 

研究负责人:

Dr. Wai Yee Wong 

Applicant:

Carol Chan 

Study leader:

Dr. Wai Yee Wong 

申请注册联系人电话:

Applicant telephone:

+852 26321764

研究负责人电话:

Study leader's
telephone:

+852 26322583

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

carolchan@cuhk.edu.hk

研究负责人电子邮件:

Study leader's E-mail:

alicewywong@cuhk.edu.hk

申请单位网址(自愿提供):

Applicant website(voluntary supply):

http://www.cct.cuhk.edu.hk/registry/publictrialrecord.aspx?trialid=CUHK_CCT00300

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

http://www.cct.cuhk.edu.hk/registry/publictrialrecord.aspx?trialid=CUHK_CCT00300

申请注册联系人通讯地址:

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

研究负责人通讯地址:

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

Applicant address:

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

Study leader's address:

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

Prince of Wales Hospital, The Chinese University of Hong Kong

Applicant's institution:

Prince of Wales Hospital, The Chinese University of Hong Kong

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

NA

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Prince of Wales Hospital

Name of the ethic committee:

Prince of Wales Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2011-08-29 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

Prince of Wales Hospital, The Chinese University of Hong Kong

Primary sponsor:

Prince of Wales Hospital, The Chinese University of Hong Kong

研究实施负责(组长)单位地址:

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

Primary sponsor's address:

1/F, Block F, Department of Obstetrics &Gynaecology, Prince of Wales Hospital

试验主办单位(项目批准或申办者):

Secondary sponsor:

经费或物资来源:

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong

Source(s) of funding:

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong

研究疾病:

infertile women undergoing oocyte retrieval  

Target disease:

infertile women undergoing oocyte retrieval

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

Music therapy on pain and stress reduction during transvaginal ultrasound-guided oocyte retrieval: a randomized controlled trial  

Objectives of Study:

Music therapy on pain and stress reduction during transvaginal ultrasound-guided oocyte retrieval: a randomized controlled trial

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Patient undergoing transvaginal ultrasound-guided oocyte retrieval

Inclusion criteria

Patient undergoing transvaginal ultrasound-guided oocyte retrieval

排除标准:

1. Patient is suffering from following disease:
(1) Deaf;
(2) Endocrine disease including diabetes mellitus, thyroid, hypothalamic, adrenal problems;
(3) On steroid therapy;
(4) Salivary gland disease;
2. Smoker or drinker;
3. Refuse or incompetence for informed consent.

Exclusion criteria:

1. Patient is suffering from following disease:
(1) Deaf;
(2) Endocrine disease including diabetes mellitus, thyroid, hypothalamic, adrenal problems;
(3) On steroid therapy;
(4) Salivary gland disease;
2. Smoker or drinker;
3. Refuse or incompetence for informed consent.

研究实施时间:

Study execute time:

From 2011-10-01 00:00:00 To 1990-01-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2011-10-01 00:00:00 To 2012-11-04 00:00:00

干预措施:

Interventions:

组别:

A

样本量:

0

Group:

A

Sample size:

干预措施:

One group of patient will be offered a MP3 machine with headphone, however, no music will be played.

干预措施代码:

Intervention:

One group of patient will be offered a MP3 machine with headphone, however, no music will be played.

Intervention code:

组别:

B

样本量:

0

Group:

B

Sample size:

干预措施:

In another group, no MP3 machine with headphone and no music will be offered.

干预措施代码:

Intervention:

In another group, no MP3 machine with headphone and no music will be offered.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中國

省(直辖市):

香港特別行政區 

市(区县):

 

Country:

China

Province:

Hong kong

City:

单位(医院):

Prince of Wales Hospital 

单位级别:

Prince of Wales Hospital 

Institution
hospital:

Prince of Wales Hospital

Level of the institution:

Prince of Wales Hospital

测量指标:

Outcomes:

指标中文名:

Assessment of pain by a 100mm linear visual analogous scale (VAS) related to transvaginal ultrasound-guided oocyte retrieval (TUGOR). Patient will be asked to give the satisfaction score regarding the pain control of TUGOR.

指标类型:

主要指标

Outcome:

Assessment of pain by a 100mm linear visual analogous scale (VAS) related to transvaginal ultrasound-guided oocyte retrieval (TUGOR). Patient will be asked to give the satisfaction score regarding the pain control of TUGOR.

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Surgeon’s perception towards adequately of pain and sedation control will be rated using same VAS and satisfactory score.

指标类型:

次要指标

Outcome:

Surgeon’s perception towards adequately of pain and sedation control will be rated using same VAS and satisfactory score.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

The additional of analgesic during and after TUGOR will be recorded.

指标类型:

主要指标

Outcome:

The additional of analgesic during and after TUGOR will be recorded.

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Blood pressure, heart rate, respiratory rate, oxygen saturation level will be measured in every 10 minutes during TUGOR.

指标类型:

主要指标

Outcome:

Blood pressure, heart rate, respiratory rate, oxygen saturation level will be measured in every 10 minutes during TUGOR.

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Assessment of anxiety and stress Basal anxiety level will be assessed by the Chinese version of the Spielberger’s State Anxiety Inventory (STAI) (Appendix I)

指标类型:

主要指标

Outcome:

Assessment of anxiety and stress Basal anxiety level will be assessed by the Chinese version of the Spielberger’s State Anxiety Inventory (STAI) (Appendix I)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

12-item General Health Questionnaire (GHQ-12) (Appendix II) and Beck Depression Inventory (BDI) (Appendix III)

指标类型:

主要指标

Outcome:

12-item General Health Questionnaire (GHQ-12) (Appendix II) and Beck Depression Inventory (BDI) (Appendix III)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Salivary for stress hormone including cortisol and amylase level will be measured before and immediately after TUGOR procedures.

指标类型:

主要指标

Outcome:

Salivary for stress hormone including cortisol and amylase level will be measured before and immediately after TUGOR procedures.

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Assessment of patient satisfaction Patient attitude towards the treatment will be assessed by an 8-item client satisfaction questionnaire (CSQ-8) (Appendix IV).

指标类型:

次要指标

Outcome:

Assessment of patient satisfaction Patient attitude towards the treatment will be assessed by an 8-item client satisfaction questionnaire (CSQ-8) (Appendix IV).

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Experience of post-operative side effect will be recorded.

指标类型:

次要指标

Outcome:

Experience of post-operative side effect will be recorded.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Sedation and co-operation scale intra-operative sedation and co-operation will be assessed by surgeon of TUGOR and will be scored according to 5-point sedation and co-operation scales.

指标类型:

次要指标

Outcome:

Sedation and co-operation scale intra-operative sedation and co-operation will be assessed by surgeon of TUGOR and will be scored according to 5-point sedation and co-operation scales.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 45 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

随机

Randomization Procedure (please state who generates the random number sequence and by what method):

randomization

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Open label

Blinding:

Open label

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2015-07-22 13:18:41